Biblio

Export 3292 results:
Author Title [ Type(Asc)] Year
Journal Article
R. McClure, Ong, H., Janve, V., Barton, S., Zhu, M., Li, B., Dawes, M., W Jerome, G., Anderson, A., Massion, P., Gore, J. C., and Pham, W., “Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 797-811, 2017.
K. E. Osborn, Alverio, J. M., Dumitrescu, L., Pechman, K. R., Gifford, K. A., Hohman, T. J., Blennow, K., Zetterberg, H., and Jefferson, A. L., “Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
B. Dubois, Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. Luis, Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M. - O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., and Cummings, J. L., “Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.”, Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
J. E. Manousakis, Scovelle, A. J., Rajaratnam, S. M. W., Naismith, S. L., and Anderson, C., “Advanced Circadian Timing and Sleep Fragmentation Differentially Impact on Memory Complaint Subtype in Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 66, no. 2, pp. 565-577, 2018.
D. L. Alkon, Sun, M. - K., Tuchman, A. J., and Thompson, R. E., “Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.”, J Alzheimers Dis, vol. 96, no. 2, pp. 759-766, 2023.
K. M. Hawkins and Sergio, L. E., “Adults at Increased Alzheimer's Disease Risk Display Cognitive-Motor Integration Impairment Associated with Changes in Resting-State Functional Connectivity: A Preliminary Study.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1161-72, 2016.
J. C. DiFrancesco, Tremolizzo, L., Polonia, V., Giussani, G., Bianchi, E., Franchi, C., Nobili, A., Appollonio, I., Beghi, E., and Ferrarese, C., “Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1267-1274, 2017.
A. Jenkins, Lindsay, S., Eslambolchilar, P., Thornton, I. M., and Tales, A., “Administering Cognitive Tests Through Touch Screen Tablet Devices: Potential Issues.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1169-1182, 2016.
E. Diehl-Wiesenecker, von Armin, C. A. F., Dupuis, L., Müller, H. - P., Ludolph, A. C., and Kassubek, J., “Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.”, J Alzheimers Dis, 2015.
M. Waragai, Ho, G., Takamatsu, Y., Wada, R., Sugama, S., Takenouchi, T., Masliah, E., and Hashimoto, M., “Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1249-1253, 2020.
O. Turró-Garriga, Calvó-Perxas, L., Vilalta-Franch, J., Hernández-Ferrándiz, M., Flaqué, M., Linares, M., Cullell, M., Gich, J., Casas, I., Perkal, H., and Garre-Olmo, J., “Adherence to Clinical Practice Guidelines during Dementia Work-Up in a Real-World Setting: A Study from the Registry of Dementias of Girona.”, J Alzheimers Dis, vol. 59, no. 3, pp. 997-1007, 2017.
B. Arosio, Casati, M., Gussago, C., Ferri, E., Abbate, C., Scortichini, V., Colombo, E., Rossi, P. Dionigi, and Mari, D., “Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target.”, J Alzheimers Dis, vol. 54, no. 2, pp. 417-25, 2016.
B. Polis and Samson, A. O., “Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1199-1218, 2024.
Q. Wang, Guo, L., Thompson, P. M., Jack, C. R., Dodge, H., Zhan, L., and Zhou, J., “The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1.”, J Alzheimers Dis, vol. 64, no. 1, pp. 149-169, 2018.
R. L. H. Handels, Joore, M. A., Vos, S. J. B., Aalten, P., Ramakers, I. H. G. B., Rikkert, M. Olde, Scheltens, P., Jansen, W. J., Visser, P. - J., van Berckel, B. M. N., van Domburg, P., Smid, M., Hoff, E., Hoogmoed, J., Bouwman, F., Claassen, J., Leentjens, A. F. G., Wolfs, C. A. G., Severens, J. L., and Verhey, F. R. J., “Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.”, J Alzheimers Dis, vol. 52, no. 3, pp. 875-85, 2016.
E. Niemantsverdriet, Feyen, B. F. E., Le Bastard, N., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Bjerke, M., and Engelborghs, S., “Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.”, J Alzheimers Dis, vol. 63, no. 1, pp. 373-381, 2018.
E. Zupanic, Kåreholt, I., Norrving, B., Secnik, J., von Euler, M., Winblad, B., Religa, D., Kramberger, M. Gregoric, Johnell, K., Eriksdotter, M., and Garcia-Ptacek, S., “Acute Stroke Care in Dementia: A Cohort Study from the Swedish Dementia and Stroke Registries.”, J Alzheimers Dis, vol. 66, no. 1, pp. 185-194, 2018.
O. Rolandsson, Tornevi, A., Steneberg, P., Edlund, H., Olsson, T., Andreasson, U., Zetterberg, H., and Blennow, K., “Acute Hyperglycemia Induced by Hyperglycemic Clamp Affects Plasma Amyloid-β in Type 2 Diabetes.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1033-1046, 2024.
I. Arrieta-Cruz, Knight, C. M., and Gutiérrez-Juérez, R., “Acute Exposure of the Mediobasal Hypothalamus to Amyloid-β25-35 Perturbs Hepatic Glucose Metabolism.”, J Alzheimers Dis, 2015.
I. Ben Ayed, Castor-Guyonvarch, N., Amimour, S., Naija, S., Aouichaoui, C., Ben Omor, S., Tabka, Z., and Massioui, F. El, “Acute Exercise and Cognitive Function in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 2, pp. 749-760, 2021.
E. Stogmann, Moser, D., Klug, S., Gleiss, A., Auff, E., Dal-Bianco, P., Pusswald, G., and Lehrner, J., “Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1043-50, 2016.
M. Fernández-Matarrubia, Goni, L., Rognoni, T., Razquin, C., Fernández-Lázaro, C. Ignacio, Bes-Rastrollo, M., Martínez-González, M. Ángel, and Toledo, E., “An Active Lifestyle Is Associated with Better Cognitive Function Over Time in APOE ɛ4 Non-Carriers.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1257-1268, 2020.
T. C. Durazzo, Korecka, M., Trojanowski, J. Q., Weiner, M. W., Hara, R. O. ', Ashford, J. W., and Shaw, L. M., “Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.”, J Alzheimers Dis, vol. 54, no. 1, pp. 99-107, 2016.
N. Ortí-Casañ, Wajant, H., H Kuiperij, B., Hooijsma, A., Tromp, L., Poortman, I. L., Tadema, N., de Lange, J. H. E., Verbeek, M. M., De Deyn, P. P., Naudé, P. J. W., and Eisel, U. L. M., “Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.”, J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.

Pages